NLRP3 and diabetes mellitus: In diabetes, NLRP3 inflammasome hyperactivation in macrophages promotes both systemic inflammation and NETosis, which then leads to a feed-forward mechanism in which NETs produce elevated levels of ILs-1β and -18 and perpetuate an environment characterized by ever increasing inflammation, NETosis, and inflammasome activation [81].